Moderna

• Health Canada approves Moderna’s combined COVID, flu shot for some

  Both of the vaccines are only approved for Canadians aged 50 and older, and it's not clear yet when they might be available to get at your pharmacy.

  Health

  Nov 6
  
• Moderna’s experimental mRNA cancer treatment progresses, shares spike

  Moderna and Merck are developing a treatment using an mRNA-based cancer vaccine designed to be tailored to individual patients based on unique mutations within their tumors.

  Health

  Aug 19
  
• Advertisement
• FDA approves Moderna’s mRNA-based vaccine for the flu

  The shot, named mFlusiva, is intended for adults age 50 or older. Moderna said late Wednesday that it expects some of its new version to be available soon at select retailers.

  U.S. News

  Aug 6
• Advertisement
• Still ‘many steps to do’ in creating a hantavirus vaccine, experts say

  Four Canadians are isolating across the country after exposure on the hantavirus-hit MV Hondius cruise ship. The outbreak has left three dead and 11 other identified cases.

  Health

  May 13
• Moderna’s latest COVID-19 vaccine is both approved and ‘made in Canada’

  An update to Moderna's COVID-19 vaccine that targets the newest variants and is made entirely within Canada's borders was just approved by Health Canada.

  Health

  Aug 25, 2025
• Moderna pulls application for U.S. approval of COVID-flu shot

  Moderna's decision comes a day after the FDA said it would require new clinical trials for approval of annual COVID-19 boosters for healthy people under 65.

  Health

  May 21, 2025
• Canada approves Moderna’s RSV vaccine, first of its kind for older adults

  Health Canada has approved the vaccine, mRESVIA, for the prevention of lower respiratory tract disease in older adults, the company said.

  Health

  Nov 8, 2024
• COVID-flu shot offers strong immune response in late-stage trial, Moderna says

  Moderna says it combination vaccine to protect against both COVID-19 and influenza generated a stronger immune response in adults 50 and over when compared to separate shots.

  Health

  Jun 10, 2024
• Advertisement
• Moderna forecasts weaker sales as COVID vaccine demand wanes

  Moderna said on Thursday its 2023 sales would only hit the low end of its previous forecast, reflecting weaker demand for COVID-19 vaccines.

  Health

  Nov 2, 2023
• Advertisement
• Moderna can meet 2023 COVID vaccine forecast, unlike Pfizer: analysts

  Around 20 million people need to be vaccinated with Moderna's updated COVID-19 vaccine for the company to reach US$2 billion in 2023 sales.

  World

  Nov 1, 2023